首页> 外文OA文献 >Effective Treatment of Established GL261 Murine Gliomas through Picornavirus Vaccination-Enhanced Tumor Antigen-Specific CD8+ T Cell Responses.

【2h】

Effective Treatment of Established GL261 Murine Gliomas through Picornavirus Vaccination-Enhanced Tumor Antigen-Specific CD8+ T Cell Responses.

机译：通过微小核糖核酸病毒疫苗接种增强的肿瘤抗原特异性CD8 + T细胞应答有效治疗已建立的GL261小鼠神经胶质瘤。

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Danielle N Renner; Fang Jin; Adam J Litterman; Alexis J Balgeman; Lisa M Hanson; Jeffrey D Gamez; Michael Chae; Brett L Carlson; Jann N Sarkaria; Ian F Parney; John R Ohlfest; Istvan Pirko; Kevin D Pavelko; Aaron J Johnson;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Cure of established GL261 mouse gliomas after combined immunotherapy with GM-CSF and IFNgamma is mediated by both CD8+ and CD4+ T-cells. [J] . Smith KE, Fritzell S, Badn W, International Journal of Cancer =: Journal International du Cancer . 2009,第3期

机译：与GM-CSF和IFNgamma联合免疫治疗后，已建立的GL261小鼠神经胶质瘤的治愈是由CD8 +和CD4 + T细胞介导的。
2. Generation of tumor antigen-specific murine CD8+ T cells with enhanced anti-tumor activity via highly efficient CRISPR/Cas9 genome editing [J] . YasuoOuchi, AshwiniPatil, YusukeTamura, International immunology. . 2018,第4期

机译：通过高效CRISPR / CAS9基因组编辑产生具有增强的抗肿瘤活性的肿瘤抗原特异性鼠CD8 + T细胞
3. Sequential immunotherapy by vaccination with GM-CSF-expressing glioma cells and CTLA-4 blockade effectively treats established murine intracranial tumors [J] . AgarwallaP., BarnardZ., FecciP., Journal of immunotherapy . 2012,第5期

机译：通过接种表达GM-CSF的神经胶质瘤细胞和CTLA-4阻断剂进行的顺序免疫疗法可有效治疗已确定的鼠颅内肿瘤
4. Murine Intestinal Bacteria Modulate Antigen-Specific Cytokine Production by Intestinal Immune Cells Derived from Germ-Free TCR-Transgenic Mice [C] . Masato Tsuda, Akira Hosono, Tsutomu Yanagibashi, Annual Meeting of the Japanese Association for Animal Cell Technology . 2009

机译：小鼠肠道细菌调节衍生自无菌TCR-转基因小鼠的肠免疫细胞的抗原特异性细胞因子产生
5. Provision of antigen-specific CD4+ T cells prevents the tolerization of CD8+ tumor-specific T cells in a mouse model of prostate cancer. [D] . Shafer-Weaver, Kimberly Ann. 2009

机译：提供抗原特异性CD4 + T细胞可防止在前列腺癌的小鼠模型中耐受CD8 +肿瘤特异性T细胞。
6. Effective Treatment of Established GL261 Murine Gliomas through Picornavirus Vaccination-Enhanced Tumor Antigen-Specific CD8+ T Cell Responses [O] . Danielle N. Renner, Fang Jin, Adam J. Litterman, -1

机译：通过小核糖核酸病毒疫苗接种增强的肿瘤抗原特异性CD8 + T细胞反应有效治疗已建立的GL261小鼠神经胶质瘤
7. Cure of established GL261 mouse gliomas after combined immunotherapy with GM-CSF and IFNgamma is mediated by both CD8(+) and CD4(+) T-cells. [O] . Enell Smith, Karin, Fritzell, Sara, Badn, Wiaam, 2009

机译：用Gm-CsF和IFNγ联合免疫治疗后建立的GL261小鼠神经胶质瘤的治疗由CD8（+）和CD4（+）T细胞介导。
8. Preparation for a Clinical Trial Using Adoptive Transfer of Tumor- Reactive TGF-Beta-Insensitive CD8+ T Cells for Treatment of Prostate Cancer [R] . Lee, C. 2006

机译：使用过继转移肿瘤反应性TGF-β不敏感CD8 + T细胞治疗前列腺癌的临床试验准备

Effective Treatment of Established GL261 Murine Gliomas through Picornavirus Vaccination-Enhanced Tumor Antigen-Specific CD8+ T Cell Responses.

著录项

引文网络

相似文献

相关主题

期刊订阅